Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

RANBAXY, CIPLA JOIN HANDS TO MARKET SELECT DRUGS

Article Abstract:

Ranbaxy and Cipla have entered into an alliance to jointly market a select range of drugs. The two pharmaceutical companies will leverage their strengths in the cardiovascular and perennial anti- infectives market. The two companies are initially launching Carvedilol, an aniti-hypertensive and Cefpodoxime Proxetil, an advanced oral cephalosporin. Ranbaxy will market the anti- hypertensive under the brand name of Caslot while Cipla will market it under the brand name of Carloc. Ranbaxy will market the oral cephalosporin under the brand name of Cepodem while Cipla will market it under the brand name of Cefoprox. Ranbaxy has developed the oral cephalosporin while Cipla has developed the anti-hypertensive and each will buy the bulk drug from the other. (khr)

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1999
Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Strategic alliances, Drugs, Ranbaxy Laboratories Ltd., Cipla Ltd.

User Contributions:

1
Benudhar Mukhi
Report this comment as inappropriate
Aug 22, 2009 @ 9:09 am
Requested
sir /Madam I am a poor & financial person & have a educational loan for
the complit of my M.sc Biomedical science (fresher).kindly give me the chance for a job in your company .
Thanks

Comment about this article or add new information about this topic:

CAPTCHA


ORCHID CHEM TO SET UP Rs50-CRORE PLANT IN TN

Article Abstract:

Orchid Chemicals & Pharmaceuticals Ltd, a major producer of cephalosporins, plans to set up a new plant at the Cuddalore chemical complex in Tamil Nadu at an estimated cost of Rs50 crore. The unit is to produce non-cephalosporin bulk drugs like Azithromycin, Clarithromycin and Roxythromycin. These are to be exported mainly to South America, the Far East and other non- patented countries. This project will be taken up after the company completes setting up its proposed formulations unit at Chennai. (khr)

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
New capacity, new plant construction, Pharmaceutical Preparation Manufacturing, Cephalosporin Preparations, Cephalosporins, Orchid Chemicals and Pharmaceuticals Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: India
Similar abstracts:
  • Abstracts: RULING MARKETS, KINGSIZE SCL TO SET UP RMC PLANTS IN M'RASHTRA. JCT ENTERS RESTRUCTURE MODE; MAJOR ASSETS ON SALE LIST
  • Abstracts: AUSTRIA: SAVINGS FROM INTERNET TICKET SALES. AUSTRIA: AUA TO SELL MORE TICKETS VIA INTERNET. EU-Kommission pr ft Billigtarife der AUA
  • Abstracts: FAR FROM DIALING THE RIGHT NUMBER TO CHEER TELECOM MOTOROLA TO SET UP WIRELESS SOLUTIONS UNIT IN HYDERABAD. RIL ALLOWED TO ENTER GLOBAL MOBILE TELECOM
  • Abstracts: RABO INDIA FIN TO MARKET SERVICES FOR MNCs. KSIDC SLASHES INTEREST RATE BY 1% ON LOANS FOR NEW IT COS
  • Abstracts: WAITING FOR SERC MAGIC. CESC TRIPS ON DEBT, IN THE RED SERC TO GET FREE HAND ON POWER TARIFF, 50% CAP TO GO
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.